Bausch Health to Announce Second Quarter 2024 Results on August 1, 2024
Bausch Health to Announce Second Quarter 2024 Results on August 1, 2024
LAVAL, Quebec, July 11, 2024 – Bausch Health Companies Inc. (NYSE/TSX: BHC) will release second quarter 2024 financial results on Thursday, August 1, 2024. Bausch Health will host a conference call and live webcast at 8:00 a.m. U.S. EST to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.
2024年7月11日加拿大拉瓦尔 - Bausch Health Companies Inc.(NYSE/TSX: BHC)将于2024年8月1日星期四发布第二季度财务业绩。 Bausch Health将于美国东部标准时间上午8:00举行电话会议和直播,讨论业绩并提供业务更新。在开始通话前,所有材料将在Bausch Health网站的投资者关系部分提供。
Conference Call Details
电话会议详情
Date: |
Thursday, August 1, 2024 |
Time: |
8:00 a.m. U.S. EST |
Webcast: |
日期: |
2024年8月1日 星期四 |
时间: |
美国东部时间上午8:00(UTC-5) |
网络直播: |
A replay of the conference call will be available on the investor relations website.
电话会议的录音重播将在投资者关系网站上提供。
To participate in the live Q&A session, please register using this link to receive an email confirming your registration.
要参加现场问答环节,请使用此链接注册并获得确认电子邮件。
About Bausch Health
关于Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, medical aesthetic devices, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit and connect with us on LinkedIn.
Bausch Health Companies Inc.(NYSE/TSX:BHC)是一家全球多元化的医药公司,通过不懈的努力提供更好的医疗保健成果来改善人们的生活。我们主要在胃肠病学、肝病学、神经病学、皮肤病学、医疗美容设备、国际药品和眼科领域开发、制造和推广一系列产品。通过我们对Bausch + Lomb的控制利益,我们的雄心壮志是成为一家全球一体化的医疗保健公司,受患者、医疗保健专业人员、员工和投资者的信任和重视。欲了解更多信息,请访问并关注我们的领英页面。
Investor Contact: | Media Contact: |
Garen Sarafian ir@bauschhealth.com (877) 281-6642(toll-free) |
Katie Savastano corporate.communications@bauschhealth.com (908) 927-1976 |
投资者联系人: | 媒体联系人: |
加伦·萨拉菲安 ir@bauschhealth.com (877)281-6642(免费电话) |
Katie Savastano corporate.communications@bauschhealth.com (908) 927-1976 |